Skip to content

Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD)

COV-IDD: Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04887129
Enrollment
392
Registered
2021-05-14
Start date
2021-05-03
Completion date
2024-03-31
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Brief summary

The purpose of this study is to understand how to prevent COVID-19 spread in a school like the Mary Cariola Center (MCC) in Rochester, NY by answering questions like these: how do activities in the school alter chances of infection? Are there people infected with the COVID-19 virus who have no symptoms? How is spread of COVID-19 affected by vaccination rates? Is there any hesitancy to get the vaccine and what are the reasons? This information will be used to help keep the school open and the students and staff safe. Eligible participants are those that work at the Mary Cariola Center (MCC) and interact with the students at MCC who have a high risk of infection from COVID-19. The study lasts for up to 16 months.

Interventions

DIAGNOSTIC_TESTCOVID-19 RT-PCR test

Participating individuals (students and employees) will be tested for COVID-19 (RT-PCR) using a specimen collected using a mid-turbinate swab. This asymptomatic testing regime starts on or after (if scheduling testing requires this to begin on a different day) enrollment and is repeated every 5-14 days for up to 16 months . Anyone testing positive is followed up as described below for symptomatic individuals. Those presenting with symptoms will be also tested for COVID-19 (RT-PCR). Those with negative test results will return to the asymptomatic testing protocol. Students who test positive are retested then 3 days until two negative tests. Employees who test positive also be tested every 3 days until two negative tests.

OTHERCOVID-19 Vaccine Education Campaign

Utilizing information from focus groups, the investigators will develop and deploy an educational campaign aimed at improving vaccine hesitancy and student health

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
University of Rochester
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
3 Years to 72 Years
Healthy volunteers
Yes

Inclusion criteria

Students: * IDD Student of the Mary Cariola Center * Age 3 - 18 * Have a parent/guardian who can give informed consent * In the judgement of the Mary Cariola Medical Staff will be able to safely participate in the study procedures (nasal swab, phlebotomy) Staff * Age 18 - 72 * Able give informed consent * Anticipated duration of remaining employment less than 1 month (e.g. retiring) * Must be willing to participate in RT-PCR and antibody testing

Exclusion criteria

Students * Contraindication to nasal swab * Contraindication to phlebotomy (e.g. anticoagulated, bleeding diathesis) Staff * Contraindication to nasal swab * Contraindication to phlebotomy (e.g. anticoagulated, bleeding diathesis)

Design outcomes

Primary

MeasureTime frameDescription
Number Infected With COVID-1916 monthsNumber of students or staff who test positive for COVID-19 at least once using a nasal swab test.
Change in the Percentage of Participants Reporting Anxietybaseline to 16 monthsAnxiety will be measured using the PROMIS-29 assessment. Participants were classified within normal range, mild, moderate or severe. They were counted as having anxiety if they were moderate or severe.
Change in the Percentage of Participants Classified as Depressedbaseline to 16 monthsDepression was measured using the PROMIS-29 assessment. Students or staff were classified within normal range, mild, moderate or severe. They were counted as having depression if they were moderate or severe.
Change in the Percentage of Participants Classified With Fatiguebaseline to 16 monthsFatigue will be measured using the PROMIS-29 assessment. Participants were classified within normal range, mild, moderate or severe. They were counted as having fatigue if they were moderate or severe.
Change in Percentage of Participants With Deficits in Social Functioningbaseline to 16 monthsSocial functioning will be measured using the PROMIS-29 assessment. Participants were classified within normal range, mild, moderate or severe. They were counted as having social functioning deficits if they were moderate or severe.

Countries

United States

Participant flow

Participants by arm

ArmCount
Students
All students enrolled at the Mary Cariola Center in Rochester, NY. All staff working at the Mary Cariola Center in Rochester, NY.
59
Staff
All students enrolled at the Mary Cariola Center in Rochester, NY. All staff working at the Mary Cariola Center in Rochester, NY.
333
Total392

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up024
Overall StudyOther29
Overall StudyWithdrawal by Subject957

Baseline characteristics

CharacteristicStudentsTotalStaff
Age, Continuous10 yearsNA years33 years
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants17 Participants14 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
41 Participants315 Participants274 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
15 Participants60 Participants45 Participants
Race (NIH/OMB)
American Indian or Alaska Native
2 Participants4 Participants2 Participants
Race (NIH/OMB)
Asian
1 Participants9 Participants8 Participants
Race (NIH/OMB)
Black or African American
8 Participants46 Participants38 Participants
Race (NIH/OMB)
More than one race
2 Participants10 Participants8 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
14 Participants66 Participants52 Participants
Race (NIH/OMB)
White
32 Participants257 Participants225 Participants
Region of Enrollment
United States
59 participants392 participants333 participants
Sex: Female, Male
Female
14 Participants267 Participants253 Participants
Sex: Female, Male
Male
31 Participants67 Participants36 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 590 / 333
other
Total, other adverse events
0 / 595 / 333
serious
Total, serious adverse events
0 / 590 / 333

Outcome results

Primary

Change in Percentage of Participants With Deficits in Social Functioning

Social functioning will be measured using the PROMIS-29 assessment. Participants were classified within normal range, mild, moderate or severe. They were counted as having social functioning deficits if they were moderate or severe.

Time frame: baseline to 16 months

Population: 29 students did not have data collected at 16 months. 165 adults did not have data collected at 16 months.

ArmMeasureValue (NUMBER)
StudentsChange in Percentage of Participants With Deficits in Social Functioning1.7 percentage of participants
StaffChange in Percentage of Participants With Deficits in Social Functioning1.2 percentage of participants
Primary

Change in the Percentage of Participants Classified as Depressed

Depression was measured using the PROMIS-29 assessment. Students or staff were classified within normal range, mild, moderate or severe. They were counted as having depression if they were moderate or severe.

Time frame: baseline to 16 months

Population: 29 students did not have data collected at 16 months. 165 adults did not have data collected at 16 months.

ArmMeasureValue (NUMBER)
StudentsChange in the Percentage of Participants Classified as Depressed-0.8 percentage of participants
StaffChange in the Percentage of Participants Classified as Depressed3.5 percentage of participants
Primary

Change in the Percentage of Participants Classified With Fatigue

Fatigue will be measured using the PROMIS-29 assessment. Participants were classified within normal range, mild, moderate or severe. They were counted as having fatigue if they were moderate or severe.

Time frame: baseline to 16 months

Population: 29 students did not have data collected at 16 months. 165 adults did not have data collected at 16 months.

ArmMeasureValue (NUMBER)
StudentsChange in the Percentage of Participants Classified With Fatigue2.3 percentage of participants
StaffChange in the Percentage of Participants Classified With Fatigue11.8 percentage of participants
Primary

Change in the Percentage of Participants Reporting Anxiety

Anxiety will be measured using the PROMIS-29 assessment. Participants were classified within normal range, mild, moderate or severe. They were counted as having anxiety if they were moderate or severe.

Time frame: baseline to 16 months

Population: 29 students did not have data collected at 16 months. 165 adults did not have data collected at 16 months.

ArmMeasureValue (NUMBER)
StudentsChange in the Percentage of Participants Reporting Anxiety11.7 percentage of participants
StaffChange in the Percentage of Participants Reporting Anxiety-0.7 percentage of participants
Primary

Number Infected With COVID-19

Number of students or staff who test positive for COVID-19 at least once using a nasal swab test.

Time frame: 16 months

Population: 12 staff members did not have a valid test for COVID

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
StudentsNumber Infected With COVID-1929 Participants
StaffNumber Infected With COVID-19141 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026